| Date Filed | Type | Description |
| 01/05/2022 |
4
| CDK ASSOCIATES, L.L.C. (10% Owner) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed of 8,060,682 shares
@ $0
Disposed of 2,220,000 options to buy
@ $2.5, valued at
$5.6M
|
|
| 10/06/2021 |
4
| Wilhoit Scott L. (Chief Commercial Officer) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 109,510 shares
@ $0
Disposed/sold 649,000 options to buy
@ $0 |
|
| 10/06/2021 |
4
| Kollender Richard S (President and CFO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 234,229 shares
@ $0
Disposed/sold 544,918 options to buy
@ $0 |
|
| 10/06/2021 |
4
| Cohen Fredric J. (Chief Medical Officer) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 160,408 shares
@ $0
Disposed/sold 868,818 options to buy
@ $0 |
|
| 10/06/2021 |
4
| JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 610,092 shares
@ $0
Disposed/sold 495,724 options to buy
@ $0 |
|
| 10/06/2021 |
4
| Steineger Hilde H (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 64,258 shares
@ $0
Disposed/sold 154,918 options to buy
@ $0 |
|
| 10/06/2021 |
4
| Steen Marten (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 64,151 shares
@ $0
Disposed/sold 154,918 options to buy
@ $0 |
|
| 10/06/2021 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 64,258 shares
@ $0
Disposed/sold 140,000 options to buy
@ $0 |
|
| 10/06/2021 |
4
| Kong Garheng (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 63,993 shares
@ $0
Disposed/sold 154,385 options to buy
@ $0 |
|
| 10/06/2021 |
4
| GILL DAVID N (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 78,058 shares
@ $0 |
|
| 10/06/2021 |
4
| LONG STEPHEN J (Chief Legal Officer) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 117,793 shares
@ $0
Disposed/sold 714,045 options to buy
@ $0 |
|
| 10/05/2021 |
4
| Wilhoit Scott L. (Chief Commercial Officer) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 27,515 shares
@ $2.06, valued at
$56.7k
|
|
| 10/05/2021 |
4
| LONG STEPHEN J (Chief Legal Officer) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 49,307 shares
@ $2.06, valued at
$101.6k
|
|
| 10/05/2021 |
4
| Kollender Richard S (President and CFO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 64,791 shares
@ $2.06, valued at
$133.5k
|
|
| 10/05/2021 |
4
| Cohen Fredric J. (Chief Medical Officer) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 51,548 shares
@ $2.06, valued at
$106.2k
|
|
| 10/05/2021 |
4
| Steen Marten (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 17,763 shares
@ $2.06, valued at
$36.6k
|
|
| 10/05/2021 |
4
| JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 334,868 shares
@ $2.06, valued at
$689.8k
|
|
| 10/05/2021 |
4
| Steineger Hilde H (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 17,763 shares
@ $2.06, valued at
$36.6k
|
|
| 10/05/2021 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 17,763 shares
@ $2.06, valued at
$36.6k
|
|
| 10/05/2021 |
4
| Kong Garheng (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 17,763 shares
@ $2.06, valued at
$36.6k
|
|
| 10/05/2021 |
4
| GILL DAVID N (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 17,763 shares
@ $2.06, valued at
$36.6k
|
|
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Steen Marten (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| GILL DAVID N (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Steen Marten (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 19,004 shares
@ $2.35, valued at
$44.7k
|
|
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| GILL DAVID N (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 19,075 shares
@ $2.35, valued at
$44.8k
|
|
|